Published in AIDS Care on September 01, 2007
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet (2010) 3.90
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr (2011) 1.97
Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep (2014) 1.23
Challenges in managing HIV in people who use drugs. Curr Opin Infect Dis (2015) 1.13
Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States. J Acquir Immune Defic Syndr (2014) 0.95
Housing Status, Medical Care, and Health Outcomes Among People Living With HIV/AIDS: A Systematic Review. Am J Public Health (2015) 0.90
Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections. World J Hepatol (2016) 0.85
HIV-1 and alcohol: interactions in the central nervous system. Alcohol Clin Exp Res (2013) 0.83
Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions. Alcohol Clin Exp Res (2016) 0.83
Antiretroviral treatment interruption and loss to follow-up in two HIV cohorts in Australia and Asia: implications for 'test and treat' prevention strategy. AIDS Patient Care STDS (2013) 0.82
Depressive symptoms, self-esteem, HIV symptom management self-efficacy and self-compassion in people living with HIV. AIDS Care (2013) 0.81
Do coping styles mediate the relationship between substance use and educational attainment and antiretroviral adherence? AIDS Behav (2012) 0.81
A randomized controlled trial of an HIV/AIDS Symptom Management Manual for depressive symptoms. AIDS Care (2012) 0.78
Factors mediating and moderating the relationship between gender and utilization of health care among Puerto Rican drug users in New York. Drug Alcohol Depend (2009) 0.77
Alcohol and associated characteristics among older persons living with human immunodeficiency virus on antiretroviral therapy. Subst Abus (2014) 0.76
Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol. BMC Public Health (2017) 0.75
Models for longitudinal data: a generalized estimating equation approach. Biometrics (1988) 27.90
Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry (2004) 15.99
Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA (2000) 14.17
The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry (1988) 12.83
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry (2001) 7.30
Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA (2001) 5.52
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS (2002) 5.21
Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry (2006) 4.78
Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am J Psychiatry (2005) 4.01
The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol (2002) 3.71
Screening for alcohol abuse using CAGE scores and likelihood ratios. Ann Intern Med (1991) 3.57
Development and validation of a self-completed HIV symptom index. J Clin Epidemiol (2001) 3.28
Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res (2004) 3.24
A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcohol Clin Exp Res (2005) 3.21
Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol (2006) 2.81
Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health (2004) 2.66
The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry (2003) 2.48
Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis (2004) 2.33
Alcohol consumption and HIV disease progression: are they related? Alcohol Clin Exp Res (2003) 2.32
Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr (2005) 2.32
Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study. Am J Med (2000) 2.31
Underdiagnosis of depression in HIV: who are we missing? J Gen Intern Med (2003) 2.21
How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? J Acquir Immune Defic Syndr (2003) 2.14
Major depression in 6050 former drinkers: association with past alcohol dependence. Arch Gen Psychiatry (2002) 1.98
Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retroviruses (2004) 1.88
Determinants of HAART discontinuation among injection drug users. AIDS Care (2005) 1.74
Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort. HIV Med (2006) 1.74
HIV treatment in drug abusers: impact of alcohol use. Addict Biol (2003) 1.72
Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory. J Urban Health (2004) 1.62
Clinical importance of HIV and depressive symptoms among veterans with HIV infection. J Gen Intern Med (2002) 1.57
Duration of highly active antiretroviral therapy regimens. Clin Infect Dis (2003) 1.50
Antiretroviral therapy, hepatitis C virus, and AIDS mortality among San Francisco's homeless and marginally housed. J Acquir Immune Defic Syndr (2005) 1.46
The use of the mini-mental state examination in recruitment for substance abuse research studies. Drug Alcohol Depend (2005) 1.45
Homeless chronicity and health-related quality of life trajectories among adults with addictions. Med Care (2005) 1.34
Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2005) 1.31
Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people. J Psychoactive Drugs (2003) 1.30
Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Antivir Ther (2004) 1.30
Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women. AIDS Care (2006) 1.28
A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus. Arch Intern Med (1995) 1.27
Intentional nonadherence due to adverse symptoms associated with antiretroviral therapy. J Acquir Immune Defic Syndr (2002) 1.09
Interruption of highly active antiretroviral therapy in HIV clinical practice: results from the Italian Cohort of Antiretroviral-Naive Patients. J Acquir Immune Defic Syndr (2005) 1.02
Discontinuation of potent antiretroviral therapy: predictive value of and impact on CD4 cell counts and HIV RNA levels. AIDS (2001) 1.01
Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection. AIDS Res Hum Retroviruses (2005) 0.99
Brief communication: detecting depression: providing high quality primary care for HIV-infected patients. Am J Med Qual (2001) 0.79
Barriers to use of free antiretroviral therapy in injection drug users. JAMA (1998) 6.67
Relation of family responsibilities and gender to the productivity and career satisfaction of medical faculty. Ann Intern Med (1998) 4.52
Inquiry about victimization experiences. A survey of patient preferences and physician practices. Arch Intern Med (1992) 3.11
Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med (1998) 2.85
The cost of obesity in Canada. CMAJ (1999) 2.71
Sexual ethics. Disclosure of HIV-positive status to partners. Arch Intern Med (1998) 2.67
Screening and intervention for alcohol problems. A national survey of primary care physicians and psychiatrists. J Gen Intern Med (2000) 2.33
Safe injection facilities in Canada: is it time? CMAJ (2001) 2.31
Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Arch Intern Med (2001) 2.25
Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am J Med (1992) 2.25
Effect of local restaurant smoking regulations on progression to established smoking among youths. Tob Control (2005) 2.22
Successful teaching in evidence-based medicine. Med Educ (2000) 1.96
Faculty perceptions of gender discrimination and sexual harassment in academic medicine. Ann Intern Med (2000) 1.93
Screening in special populations: a "case study" of recent Vietnamese immigrants. Am J Med (1997) 1.89
Science, sex and semantics: the firing of George Lundberg. CMAJ (1999) 1.89
Relation between local restaurant smoking regulations and attitudes towards the prevalence and social acceptability of smoking: a study of youths and adults who eat out predominantly at restaurants in their town. Tob Control (2004) 1.88
Intimate details of the conformational characteristics of deoxyribodinucleoside monophosphates in aqueous solution. J Am Chem Soc (1977) 1.84
Think HIV: why physicians should lower their threshold for HIV testing. Arch Intern Med (1999) 1.74
Determinants of HAART discontinuation among injection drug users. AIDS Care (2005) 1.74
Physician unawareness of serious substance abuse. Am J Drug Alcohol Abuse (1997) 1.54
Delays in protease inhibitor use in clinical practice. J Gen Intern Med (1999) 1.54
Screening and intervention for illicit drug abuse: a national survey of primary care physicians and psychiatrists. Arch Intern Med (2001) 1.49
Biosynthetic response and mechanical properties of articular cartilage after injurious compression. J Orthop Res (2001) 1.47
Preparation of a decadeoxyribonucleotide helix for studies by nuclear magnetic resonance. Biochemistry (1980) 1.47
Management of adults recovering from alcohol or other drug problems: relapse prevention in primary care. JAMA (1998) 1.46
Evaluation of red blood cell transfusion practices with the use of preset criteria. CMAJ (1994) 1.46
Proton nuclear magnetic resonance studies on dideoxyribonucleoside methylphosphonates. Biochemistry (1980) 1.42
Complications associated with Staphylococcus aureus bacteremia. Arch Intern Med (1984) 1.30
A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus. Arch Intern Med (1995) 1.27
The functioning and well being of persons who seek treatment for drug and alcohol use. J Subst Abuse (1998) 1.26
Nuclear Overhauser effect as a tool for the complete assignment of nonexchangeable proton resonances in short deoxyribonucleic acid helices. Biochemistry (1983) 1.25
The onset of HIV infection in the Leningrad region of Russia: a focus on drug and alcohol dependence. HIV Med (2004) 1.24
Co-morbidity of infectious and addictive diseases in St. Petersburg and the Leningrad Region, Russia. Eur Addict Res (2006) 1.22
Association of alcohol consumption with HIV sex- and drug-risk behaviors among drug users. J Subst Abuse Treat (2001) 1.21
Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy. J Clin Oncol (2001) 1.18
MEIS1 and HOXA7 genes in human acute myeloid leukemia. Leuk Res (2000) 1.18
Alcohol abuse and dependence in Latinos living in the United States: validation of the CAGE (4M) questions. Arch Intern Med (1999) 1.13
Validation of the screening strategy in the NIAAA "Physicians' Guide to Helping Patients with Alcohol Problems". J Stud Alcohol (2001) 1.13
Factors associated with initiation of primary medical care for HIV-infected persons. Am J Med (1994) 1.12
Tests of glycemia in diabetes mellitus. Their use in establishing a diagnosis and in treatment. Ann Intern Med (1989) 1.10
The substance-using human immunodeficiency virus patient: approaches to outpatient management. Am J Med (1996) 1.10
Brief interventions with substance-abusing patients. Med Clin North Am (1997) 1.07
Proton nuclear magnetic resonance study of a self-complementary decadeoxyribonucleotide, C-C-A-A-G-C-T-T-G-G. Biochemistry (1982) 1.07
Improving participation in HIV clinical trials: impact of a brief intervention. HIV Clin Trials (2001) 1.06
Victimization among substance-abusing women. Worse health outcomes. Arch Intern Med (1997) 1.03
Outpatient pharmacy care and HIV viral load response among patients on HAART. AIDS Care (2004) 1.03
Adolescents' preferences regarding human immunodeficiency virus (HIV)-related physician counseling and HIV testing. Pediatrics (1995) 1.02
The doctor-patient relationship and HIV-infected patients' satisfaction with primary care physicians. J Gen Intern Med (2000) 1.00
Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users. HIV Med (2008) 0.97
Screening for diabetes mellitus. Ann Intern Med (1988) 0.97
Contributions of the PO ester and CO torsion angles of the phosphate group to 31P-nuclear magnetic shielding constant in nucleic acids: theoretical and experimental study of model compounds. Biopolymers (1984) 0.96
Co-culture of mechanically injured cartilage with joint capsule tissue alters chondrocyte expression patterns and increases ADAMTS5 production. Arch Biochem Biophys (2009) 0.96
Physical and sexual violence and health care utilization in HIV-infected persons with alcohol problems. AIDS Care (2005) 0.94
HIV-associated risk factors among young Canadian Aboriginal and non-Aboriginal men who have sex with men. Int J STD AIDS (1999) 0.93
Recurrence of post-traumatic stress disorder symptoms after initiation of antiretrovirals including efavirenz: a report of two cases. HIV Med (2003) 0.93
Management of hospitalized intravenous drug users: role of the internist. Am J Med (1994) 0.92
Necrotizing fasciitis secondary to group A streptococcus. Morbidity and mortality still high. Can Fam Physician (2000) 0.91
Conformational study of two short pentadeoxyribonucleotides, d-CpCpApApG and d-CpTpTpGpG, and their fragments by proton nuclear magnetic resonance. Biochemistry (1982) 0.90
The value of acupuncture detoxification programs in a substance abuse treatment system. J Subst Abuse Treat (1999) 0.90
An effective method for the assignment of 31P-NMR resonance(s) of oligonucleotides. Biopolymers (1982) 0.88
Sexually transmitted infections among HIV-infected heavy drinkers in St Petersburg, Russia. Int J STD AIDS (2012) 0.87
Spatial configuration of deoxyribotrinucleoside diphosphates in aqueous solution. Nucleic Acids Res (1978) 0.87
Evolution of depressive symptoms in human immunodeficiency virus-infected patients entering primary care. J Nerv Ment Dis (2001) 0.87
The linkage of primary care services with substance abuse treatment: new opportunities for academic generalists. J Gen Intern Med (1993) 0.86
Modelling the potential economic impact of viral load-driven triple drug combination antiretroviral therapy. Pharmacoeconomics (1998) 0.86
Cross cultural adaptation of the Injection Drug User Quality Of Life Scale (IDUQOL) in Spanish drug dependent population, with or without injectable consumption: Drug User Quality of Life Scale-Spanish (DUQOL-Spanish). Addict Behav (2006) 0.85
Conformational flexibility of the 3' acceptor end of transfer ribonucleic acid. Biochemistry (1980) 0.85
Impact of parental home smoking policies on policy choices of independently living young adults. Tob Control (2009) 0.85
AIDS in intravenous drug users: issues related to enrollment in clinical trials. J Acquir Immune Defic Syndr (1990) 0.84
Transactional sex risk and STI among HIV-infected female sex workers and HIV-infected male clients of FSWs in India. AIDS Care (2011) 0.83
Controversies in the management of HIV-related illnesses. J Gen Intern Med (1991) 0.82
Disclosure of HIV status. AIDS Patient Care STDS (1999) 0.82
Managed care of substance abuse disorders. Implications for generalist physicians. Med Clin North Am (1997) 0.81
Binge drinking and unsafe sex: a study of narcology hospital patients from St. Petersburg, Russia. Subst Abus (2009) 0.81
Improving alcoholism treatment across the spectrum of services. Alcohol Clin Exp Res (2001) 0.80
Evidence-based medicine and the real world: understanding the controversy. J Eval Clin Pract (1999) 0.79
Correlates of any condom use among Russian narcology patients reporting recent unprotected sex. AIDS Behav (2008) 0.79
Brief communication: detecting depression: providing high quality primary care for HIV-infected patients. Am J Med Qual (2001) 0.79
Quality of life, needs, and interest among cocaine users: differences by cocaine use intensity and lifetime severity of addiction to cocaine. Subst Use Misuse (2010) 0.78
Compounds leached from quinoa seeds inhibit matrix metalloproteinase activity and intracellular reactive oxygen species. Int J Cosmet Sci (2015) 0.78
Generalized lymphadenopathy. J Gen Intern Med (1987) 0.78
1H- and 13C-NMR studies on caffeine and its interaction with nucleic acids. Biopolymers (1980) 0.78
Homocysteine levels and cognitive function scores measured with MMSE and BCAT of middle-aged and elderly subjects in Tianjin City. J Nutr Health Aging (2013) 0.78
Synthesis and characterization of the dinucleoside monophosphates containing 2'-fluoro-2'-deoxyadenosine. Biochemistry (1981) 0.77
Nuclear magnetic resonance study of the impact of ribose 2'-O-methylation on the aqueous solution conformation of cytidylyl-(3' leads to 5')-cytidine. Biopolymers (1977) 0.77
A call for papers. Substance abuse: innovations in primary care. J Gen Intern Med (2001) 0.76
Lithium carbonate in the treatment of schizophrenia and schizo-affective disorder: review and hypothesis. Biol Psychiatry (1979) 0.76
Talking about treatment. Ann Intern Med (2000) 0.75
Continued zidovudine or didanosine for human immunodeficiency virus infection. N Engl J Med (1992) 0.75
Do the poor sue more? JAMA (1994) 0.75
History of intimate partner violence is associated with sex work but not sexually transmitted infection among HIV-positive female drinkers in Russia. Int J STD AIDS (2013) 0.75
Screening tests for alcohol use disorders. Ann Intern Med (1999) 0.75
Patients with alcohol problems. N Engl J Med (1998) 0.75
Managing alcohol withdrawal in the elderly. Drugs Aging (1999) 0.75